PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,463
+724.5%
25,317
+183.3%
0.01%
+350.0%
Q2 2023$420
+12.0%
8,9380.0%0.00%0.0%
Q1 2023$375
+10.0%
8,9380.0%0.00%0.0%
Q4 2022$341
-99.9%
8,9380.0%0.00%0.0%
Q3 2022$350,000
+21.1%
8,9380.0%0.00%0.0%
Q2 2022$289,000
-2.4%
8,9380.0%0.00%
+100.0%
Q1 2022$296,000
-22.1%
8,9380.0%0.00%
-50.0%
Q4 2021$380,000
-4.0%
8,9380.0%0.00%0.0%
Q3 2021$396,000
-22.0%
8,9380.0%0.00%0.0%
Q2 2021$508,000
-24.1%
8,9380.0%0.00%
-33.3%
Q1 2021$669,000
-13.5%
8,9380.0%0.00%
-25.0%
Q4 2020$773,000
+41.6%
8,9380.0%0.00%
+33.3%
Q3 2020$546,000
+46.8%
8,9380.0%0.00%
+50.0%
Q2 2020$372,000
+44.7%
8,9380.0%0.00%0.0%
Q1 2020$257,000
-55.5%
8,938
+11.9%
0.00%
-33.3%
Q4 2019$577,000
-48.5%
7,9870.0%0.00%
-57.1%
Q3 2019$1,120,000
-23.4%
7,9870.0%0.01%
-22.2%
Q2 2019$1,462,000
-4.4%
7,987
-16.9%
0.01%
-10.0%
Q1 2019$1,530,000
+130.1%
9,617
+38.4%
0.01%
+100.0%
Q4 2018$665,000
-32.4%
6,947
-0.3%
0.01%
-16.7%
Q3 2018$984,000
+32.1%
6,966
+46.4%
0.01%
+20.0%
Q2 2018$745,000
+50.5%
4,757
+54.9%
0.01%
+66.7%
Q1 2018$495,000
-2.2%
3,0720.0%0.00%0.0%
Q4 2017$506,0003,0720.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders